Aimco Pesticides Ltd Q4 FY25 Results & Concall Highlights: Revenue, Margins & Order Book

Q4 FY25 earnings call analysis: revenue, margin, capex, fundraise and order book outlook from management commentary.

Published 3 Aug 2026 | Fertilizers & Agrochemicals | Market Cap: ₹48 Cr

FY26 revenue target: Approximately ₹225 crore, reflecting a cautious growth approach. Aimco Pesticides targets a cautious 10% revenue growth for FY26, aiming for a top line around ₹225 crore.

From Aimco Pesticides Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Price

47.2

Market Cap

₹48 Cr

How does Aimco Pesticides Ltd rank in Fertilizers & Agrochemicals?

Compare Aimco Pesticides Ltd against every Fertilizers & Agrochemicals company this quarter on revenue, margins and earnings-call signals.

Revenue: Rank 3Margin: Rank 3
View Fertilizers & Agrochemicals leaderboard →

Aimco Pesticides Ltd — Quarterly revenue & net profit

Revenue Net Profit
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025

Reported quarterly figures (₹ Cr). Latest: revenue ₹30 Cr, net profit ₹-3 Cr.

Full financials →

📊 Revenue & Sales Performance

Rank 3
  • FY26 revenue target: Approximately ₹225 crore, reflecting a cautious growth approach.
  • Aimco expects to remain profitable in FY26, focusing on positive EBITDA rather than aggressive topline growth.
  • Brand sale formulation business targeted for 20% year-on-year growth.
  • Increased production capacity and tie-ups enhance formulation brand sales capacity.
  • New molecules launched and under registration to drive next-year volume growth, especially in technical manufacturing.
  • Volume growth observed in active ingredients (~25%), but value growth constrained due to price declines.
  • Expansion plans include new markets (e.g., Brazil, Australia, Indonesia, US) and new product additions.
  • Existing bulk formulation sales rising (from 9% in 2023 to 24% in 2025), but company aims to limit bulk sales focus in favor of brand sale profitability.
  • Inventory levels being optimized to improve operational efficiency.

See what Aimco Pesticides Ltd said on profitability & margins — free account, 30 seconds.

🏗️ Capital Expenditure Plans

Yes
  • Aimco Pesticides has CapEx plans to increase production capacity for two new molecules already started.
  • No specific timeline set for the execution of these CapEx plans; implementation will be based on customer negotiations and confirmed business volumes.
  • Other planned CapEx includes small investments focused on safety improvements and debottlenecking existing processes.
  • Capital infusion has been made by promoters through a preferential issue of 2 lakh shares to support operations and growth.
  • The company is cautious about growth to maintain profitability and is closely managing costs and margins amid market challenges.

See what Aimco Pesticides Ltd said on fundraising & capital structure — free account, 30 seconds.

📋 Order Book & Pipeline

No information
  • The company is actively pursuing bulk formulation business opportunities, especially with a new molecule started last year that has good potential for B2B and brand sales.
  • Current volumes with UPL are growing, with the plant running at almost full capacity and expectations of even higher volumes this year.
  • Discussions are ongoing with UPL for new molecules, though timelines and commercializations are uncertain.
  • They have started initial orders and tie-ups in Brazil for products like Bifenthrin formulation and Triclopyr, with expected sales of around 200-300 tons for Triclopyr in Brazil (~₹100 crore value).
  • New molecules under registration in various countries and pilot trials are ongoing.
  • No specific numeric order book was mentioned, but the company targets ₹225 crore revenue in FY26, focusing on profitable growth rather than aggressive scaling.
  • The company is cautious and focused on margin improvement alongside volume growth.

Key Metrics

1 of 5 growth signals positive in the Q4 FY25 call.

Revenue

Rank 3

Margin

Rank 3

Capex

Yes

Fundraise

No information

Order Book

No information

How does Aimco Pesticides Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature
1Aimco Pesticides Ltd
Rev 3Mar 3

See full Fertilizers & Agrochemicals sector rankings

Others in Fertilizers & Agrochemicals this season

  • SHARDACROP (Q4 FY25)

    Globally, the company’s current 4%-5% global market share offers scope to increase, meaning a 1% global share gain equates to 20%-25% volume growth for them…

  • RALLIS (Q4 FY25)

    Export business has seen some recovery with a 6% growth in volume and price in Q4, suggesting improving order flow. Key concall takeaways from Rallis India's…

  • PUNJABCHEM (Q4 FY25)

    The company has created inventory strategically to honor its existing order book positions, with about INR25 crores of inventory lying in transit as of March…

  • Gujarat State Fertilizers & Chemicals Ltd (Q4 FY25)

    FY '25 manufacturing volumes were 1.6 million tons, a 15% YoY growth. Key concall takeaways from Gujarat State Fertilizers & Chemicals Ltd's Q4 FY25 earnings…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Aimco Pesticides Ltd Q4 FY25 results?

FY26 revenue target: Approximately ₹225 crore, reflecting a cautious growth approach. Aimco Pesticides targets a cautious 10% revenue growth for FY26, aiming for a top line around ₹225 crore.

What is Aimco Pesticides Ltd share price analysis?

Aimco Pesticides Ltd currently shows a below-average growth signal. The stock trades at a P/E of N/A with a market cap of ₹48 Cr. Investors should review the full earnings analysis for detailed insights.

Is Aimco Pesticides Ltd planning capital expenditure?

Aimco Pesticides has CapEx plans to increase production capacity for two new molecules already started.

Keep Aimco Pesticides Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.